Braskem SA ADR (BAK)
1.9500
-0.1200 (-5.80%)
NYSE· Last Trade: Aug 14th, 10:16 PM EDT
Braskem (NYSE:BAK) reported recurring EBITDA of $1.043 billion for the second quarter of 2026, supported by wider international petrochemical spreads following supply disruptions linked to the Middle East conflict. The company said the improvement was tactical rather than evidence of a structural re
Via MarketBeat · August 14, 2026
Braskem (NYSE:BAK) reported a sharp sequential improvement in first-quarter 2026 recurring EBITDA, while management said cash preservation and capital-structure discussions remain central priorities amid a volatile petrochemical market and elevated leverage.
Rosana Avolio, Braskem’s director of inv
Via MarketBeat · May 14, 2026
The US Mont Belvieu butane market is currently grappling with a significant downturn, as prices have been in a state of sustained weakness throughout late 2025. This persistent slump is primarily attributable to a confluence of factors: an oversupply of butane stemming from robust domestic production and elevated inventories, coupled
Via MarketMinute · October 28, 2025

Via Benzinga · November 22, 2024
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page.
Via Benzinga · September 29, 2025
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page.
Via Benzinga · September 26, 2025

Braskem's leadership in sustainable bioplastics offers a compelling investment for those seeking profit and environmental responsibility.
Via MarketBeat · January 24, 2025

Via Benzinga · December 9, 2024

Braskem just reported results for the first quarter of 2024.
Via InvestorPlace · May 9, 2024

BAK stock results show that Braskem missed analyst estimates for earnings per share the fourth quarter of 2023.
Via InvestorPlace · March 19, 2024

Via Benzinga · September 18, 2024

BAK stock results show that Braskem missed analyst estimates for earnings per share but beat on revenue for the second quarter of 2024.
Via InvestorPlace · August 12, 2024

Via Benzinga · May 6, 2024

Via Benzinga · May 6, 2024

The U.S. corporate bond market had mixed performance in Q1, with higher-rated bonds seeing slight declines and lower-rated bonds showing modest gains. Top performers include Macy's, Ally Financial, and Lincoln National Corp.
Via Benzinga · April 5, 2024

U.S. stocks were mixed, with the Dow Jones index gaining around 0.1% on Wednesday.
Via Benzinga · March 20, 2024

U.S. stocks traded mostly lower, with the Dow Jones falling around 75 points on Thursday. Here are some big stocks recording gains in today’s session.
Via Benzinga · November 9, 2023

Gainers Intelligent Bio Solutions Inc. (NASDAQ: INBS) shares climbed 83.5% to $0.4169 after reporting first-quarter results.
Via Benzinga · November 9, 2023

Gainers Intelligent Bio Solutions Inc. (NASDAQ: INBS) shares surged 111.9% to $0.4810 in pre-market trading after reporting first-quarter results.
Via Benzinga · November 9, 2023

It's time to start the day with a breakdown of the biggest pre-market stock movers worth keeping tabs on for Thursday morning!
Via InvestorPlace · November 9, 2023

Find out why investment bank analysts are pounding the table on these stocks.
Via The Motley Fool · October 15, 2023

These stocks have taken a tumble, but the investment bank analysts who follow them still think they can produce eye-popping returns.
Via The Motley Fool · September 26, 2023

Via Benzinga · July 5, 2023
